Simplex Trading
XENE icon

Simplex Trading’s Xenon Pharmaceuticals XENE Stock Holding History

Simplex Trading’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.98M Buy
51,300
+49,900
+3,564% +$2.3M ﹤0.01% 1507
2025
Q4 		$62.7K Sell
1,400
-14,800
-91% -$622K ﹤0.01% 5451
2025
Q3 		$650K Sell
16,200
-800
-5% -$28.2K ﹤0.01% 3513
2025
Q2 		$532K Buy
17,000
+15,400
+963% +$502K ﹤0.01% 3445
2025
Q1 		$53K Sell
1,600
-4,300
-73% -$163K ﹤0.01% 5714
2024
Q4 		$231K Sell
5,900
-11,100
-65% -$459K ﹤0.01% 4368
2024
Q3 		$669K Sell
17,000
-5,400
-24% -$218K ﹤0.01% 3290
2024
Q2 		$873K Buy
22,400
+7,400
+49% +$296K ﹤0.01% 3061
2024
Q1 		$645K Buy
15,000
+12,500
+500% +$575K ﹤0.01% 3594
2023
Q4 		$115K Sell
2,500
-28,500
-92% -$1.01M ﹤0.01% 5243
2023
Q3 		$1.06M Buy
31,000
+26,700
+621% +$999K ﹤0.01% 2606
2023
Q2 		$165K Sell
4,300
-46,800
-92% -$1.86M ﹤0.01% 4526
2023
Q1 		$1.83M Sell
51,100
-29,900
-37% -$1.1M ﹤0.01% 2024
2022
Q4 		$3.19M Buy
81,000
+79,800
+6,650% +$2.91M ﹤0.01% 1519
2022
Q3 		$43K Sell
1,200
-2,700
-69% -$97.1K ﹤0.01% 6656
2022
Q2 		$118K Buy
3,900
+1,000
+34% +$30.2K ﹤0.01% 5349
2022
Q1 		$88K Sell
2,900
-28,300
-91% -$847K ﹤0.01% 6335
2021
Q4 		$974K Buy
31,200
+30,000
+2,500% +$896K ﹤0.01% 2883
2021
Q3 		$22K Buy
1,200
+400
+50% +$6.95K ﹤0.01% 8373
2021
Q2 		$14K Buy
800
+793
+11,329% +$14.6K ﹤0.01% 8889
2021
Q1 		$12K Buy
+7
New +$119 ﹤0.01% 7815
2020
Q3 		– Sell
-3
Closed -$3K – 8649
2020
Q2 		$3K Hold
3
– – ﹤0.01% 7187
2020
Q1 		$3K Buy
+3
New +$43 ﹤0.01% 7105
2019
Q2 		– Sell
-10
Closed -$10K – 7898
2019
Q1 		$10K Buy
+10
New +$85 ﹤0.01% 6166
2018
Q4 		– Sell
-5
Closed -$6K – 7938
2018
Q3 		$6K Hold
5
– – ﹤0.01% 6706
2018
Q2 		$4K Buy
+5
New +$31 ﹤0.01% 6828

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Simplex Trading's XENE Position: Q3 2024 in Review

Simplex Trading sold out of Xenon Pharmaceuticals (XENE) in Q3 2024, closing a stake of 2,589 shares — an estimated $104K sold.

Simplex Trading first reported a position in XENE in Q2 2020 and held it in 10 quarters. The position peaked at $1.31M in Q4 2023. 203 funds tracked by Wall St. Rank hold XENE as of Q3 2024.

  • Simplex Trading reported no remaining Xenon Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 2,589 Xenon Pharmaceuticals shares in Q3 2024, an estimated $104K.
  • Simplex Trading first reported a position in Xenon Pharmaceuticals in Q2 2020 and held it in 10 quarters.
  • Simplex Trading's Xenon Pharmaceuticals position peaked at $1.31M in Q4 2023.
  • 203 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.